Search: L773:1862 8354 OR L773:1862 8346
> (2010-2014) >
Viewpoints in Clini...
Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?
-
- Borrebaeck, Carl (author)
- Lund University,Lunds universitet,Institutionen för immunteknologi,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Immunotechnology,Departments at LTH,Faculty of Engineering, LTH
-
(creator_code:org_t)
- 2012-08-28
- 2012
- English.
-
In: Proteomics Clinical Applications. - : Wiley. - 1862-8354 .- 1862-8346. ; 6:7-8, s. 343-345
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Proteomics has not delivered biomarkers of clinical value, despite massive efforts. The technologies that are emerging today have, however, the power to reach deep into proteomes and to identify patterns associated with different diseases. The study design is then crucial and sample quality, bioinformatic approaches, pre-validation, using independent patient cohort, need to attract increased attention before proteomics will contribute to the needs of personalized medicine.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
Keyword
- over-fitting
- biobanks
- pre-validation
- bioinformatics
- Signatures
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database